Renal amyloidosis with emphasis on the diagnostic role of electron microscopy

References

• Lin CY, Gurlo T, Kayed R, et al. Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced beta-cell apoptosis in h-IAPP transgenic mice. Diabetes. 2007;56(5):1324–1332. doi:10.2337/db06-1579.
   PubMed Web of Science ®Google Scholar
• Nilsson MR. Techniques to study amyloid fibril formation in vitro. Methods. 2004;34(1):151–160. doi:10.1016/j.ymeth.2004.03.012.
   PubMed Web of Science ®Google Scholar
• Fändrich M. On the structural definition of amyloid fibrils and other polypeptide aggregates. Cell Mol Life Sci. 2004;64(16):2066–2078. doi:10.1007/s00018-007-7110-2.
   Google Scholar
• Sipe JD, Cohen AS. Review: history of the amyloid fibril. J Struct Biol. 2000;130(2–3):88–98. doi:10.1006/jsbi.2000.4221.
   PubMed Web of Science ®Google Scholar
• Ogg CS, Cameron JS, Williams DG, et al. Presentation and course of primary amyloidosis in the kidney. Clin Nephrol. 1981;15:9–13.
   PubMed Web of Science ®Google Scholar
• Lachman HJ, Goodman HJ, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356:2361–2371. doi:10.1056/NEJMoa070265.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Saniter T. Morphological and clinical features of renal amyloidosis. Virchow Arch. 1975;366:125–135. doi:10.1007/BF00433586.
   PubMed Web of Science ®Google Scholar
• Moutzouris DA, Herlitz L, Appel GB, et al. Renal biopsy in the very elderly. Clin J Am Soc Nephrol. 2009;4:1073–1082. doi:10.2215/CJN.00990209.
   PubMed Web of Science ®Google Scholar
• Falck HM, Tornroth T, Wegelius O. Predominantly vascular amyloid deposition in the kidney with minimal or no proteinuria. Clin Nephrol. 1983;19:137–142.
   PubMed Web of Science ®Google Scholar
• Rivera E, Gil CM, Gil MT, et al. Vascular renal AA amyloidosis in adult still’s disease. Nephrol Dial Transplant. 1997;12:1714–1716. doi:10.1093/ndt/12.8.1714.
   PubMed Web of Science ®Google Scholar
• Herrera GA, Picken MM. Renal diseases associated with plasma cell dyscrasias, amyloidoses, and waldenstrom macroglobulinemia. In: Jennette JC, Olson JL, Silva FG, D’Agati VD, eds. Heptinstall's Pathology of the Kidney. 7th ed. Philadelphia, Baltimore, New York, London, Hong Kong, Sydney, Tokyo: Wolters Kluwer; 2014:1015–1037, Chapter 22.
   Google Scholar
• Sethi S, Theis JD, Shiller SM, et al. Medullary amyloidosis associated with apolipoprotein A-IV deposition. Kidney Int. 2012;81:201–206. doi:10.1038/ki.2011.316.
   PubMed Web of Science ®Google Scholar
• Lobato L, Rocha A. Transthyretin amyloidosis and the kidney. CJASN. 2012;7(8):1337–1346. doi:10.2215/CJN.08720811.
   PubMed Web of Science ®Google Scholar
• Clement CG, Truong LD. An evaluation of Congo red fluorescence for the diagnosis of amyloidosis. Hum Pathol. 2014;45(8):1766–1772. doi:10.1016/j.humpath.2014.04.016.
   PubMed Web of Science ®Google Scholar
• Picken MM, Herrera GA. Thioflavin T stain: an easier and more sensitive method for amyloid detection. In: Picken MM, Dogan A, Herrera GA, eds. Amyloid and Related Disorders. Surgical Pathology and Clinical Correlations. Totowa, New Jersey: Humana Press; 2012:187–89, Chapter 22.
   Google Scholar
• Iskandar SS, Herrera GA. Glomerulopathies with organized deposits. Sem Diagn Pathol. 2002;19:116–132.
   PubMed Web of Science ®Google Scholar
• Howell D, Gu X, Herrera GA. Organized deposits and look-alikes. Ultrastruct Pathol. 2003;27:295–312. doi:10.1080/01913120390231555.
   PubMed Web of Science ®Google Scholar
• Herrera GA, Turbat-Herrera EA. Renal diseases with organized deposits: an algorithmic approach to classification and diagnosis. Arch Pathol Lab Med. 2010;134:512–531.
   PubMed Web of Science ®Google Scholar
• Larsen CP, Walker PD, Weiss DT, et al. Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies. Kidney Int. 2010;77(9):816–819. doi:10.1038/ki.2010.9.
   PubMed Web of Science ®Google Scholar
• Comenzo RL, Zhang Y, Martinez C, et al. The tropism of organ involvement in primary systemic amyloidosis. Contributions of the Ig VL germline gene use and clonal plasma cell burden. Blood. 2001;98:714–720. doi:10.1182/blood.V98.3.714.
   PubMed Web of Science ®Google Scholar
• Dogan A. Classification of amyloidosis by mass spectrometry-based proteomics. In: Picken MM, Dogan A, Herrera GA, eds. Amyloid and Related Disorders in Surgical Pathology and Clinical Correlations. New York, Dordrecht, Heidelberg, London: Springer; 2012:261–272.
   Google Scholar
• Sethi S, Theis JD, Vrana JA, et al. Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic glomerulopathy, fibrillary GN and immunotactoid glomerulopathy. Clin J Am Soc Nephrol. 2013;18:915–921. doi:10.2215/CJN.07030712.
   Web of Science ®Google Scholar
• Sethi S, Vrana J, Theis JD, Dogan A. Mass spectrometry based proteomics in the diagnosis of kidney disease. Curr Opin Nephrol Hypertens. 2013;22:273–280.
   PubMed Web of Science ®Google Scholar
• Picken MM, Herrera GA. The burden of “sticky” amyloid: typing challenges. Arch Pathol Lab Med. 2007;131:850–851.
   PubMed Web of Science ®Google Scholar
• Dogan A, Theis JD, Vrana JA. Mass spectrometry based proteinomics for classification of amyloidosis: Mayo Clinic experience. In: Hazenberg PD, Bitzet J, Gameren II, et al., eds. XIIth International Symposium on Amyloidosis; Groningen: UMCG;2013:183–185.
   Google Scholar
• Cohen AS, Calkins E. Electron microscopic observation on a fibrous component in amyloid of diverse origins. Nature. 1959;183:1202–1203. doi:10.1038/1831202a0.
   PubMed Web of Science ®Google Scholar
• Shirahama T, Cohen AS. High resolution electron microscopic analysis of the amyloid fibril. J Cell Biol. 1967;33:679–727. doi:10.1083/jcb.33.3.679.
   PubMed Web of Science ®Google Scholar
• Shirahama T, Cohen AS. Fine structure of the glomerulus in human and experimental amyloidosis. Am J Pathol. 1973;73:97–114.
   PubMed Web of Science ®Google Scholar
• Gueft G, Ghidoni JJ. The site of formation and ultrastructure of amyloid. Am J Pathol. 1963;43:837–854.
   PubMed Web of Science ®Google Scholar
• von Gise H, Christ H, Bohle A. Early glomerular lesions in amyloidosis. Virchows Arch A. 1981;390:259–272. doi:10.1007/BF00496558.
   PubMed Web of Science ®Google Scholar
• Tasoni A, Barbiano Di Belgiojoso G, Nebuloni M. Electron microscopy in the diagnosis of amyloidosis. In: Sarantseva S, ed. Amyloidosis: Mechanisms and Prospects for Therapy. InTech; 2011: Chapter 7. ISBN: 978-953-307-253-1. doi:10.5772/19102.
   Google Scholar
• Veeramachaneni R, Gu X, Herrera GA. Atypical amyloidosis: diagnostic challenges and the role of immunoelectron microscopy in diagnosis. Ultrastruct Pathol. 2004;28:75–82.
   PubMed Web of Science ®Google Scholar
• Miura K, Khirasawa H. Amyloid A (AA) fibril formation in renal tubules occurs intracytoplasmically, possibly at the site of membrane assembling structures. Amyloid. 1994;1:107–113. doi:10.3109/13506129409148633.
   Web of Science ®Google Scholar
• El-Zoghby Z, Lager D, Gregoire J, et al. Intra-tubular amyloidosis. Kidney Int. 2007;72(10):1282–1288. doi:10.1038/sj.ki.5002411.
   PubMed Web of Science ®Google Scholar
• Tagouri Y, Sanders PW, Picken MM, et al. In vitro AL-amyloid formation by rat and human mesangial cells. Lab Invest. 1996;74:290–302.
   PubMed Web of Science ®Google Scholar
• Solomon A, Weiss DT, Schell M, et al. Transgenic mouse model of AA amyloidosis. Am J Pathol. 1999;154:1267–1272. doi:10.1016/S0002-9440(10)65378-3.
   PubMed Web of Science ®Google Scholar
• Russell WJ, Cardelli J, Harris E, et al. Monoclonal light chain-mesangial cells interactions: early signaling events and subsequent pathologic effects. Lab Invest. 2001;81:889–903. doi:10.1038/labinvest.3780278.
   Web of Science ®Google Scholar
• Teng J, Turbat-Herrera EA, Herrera GA. Extrusion of amyloid fibrils to the extracellular space in experimental mesangial AL-amyloidosis: transmission and scanning electron microscopy studies and correlation with renal biopsy observations. Ultrastruct Pathol. 2014;38:104–115. doi:10.3109/01913123.2013.861568.
   PubMed Web of Science ®Google Scholar
• Vora M, Kevil CG, Herrera GA. Contribution of human smooth muscle cells to amyloid angiopathy in AL (light chain) amyloidosis. Ultrastruct Pathol. 2017;41:358368. doi:10.1080/01913123.2017.1349852.
   Web of Science ®Google Scholar
• Shirahama T, Cohen AS. Intralysosomal formation of amyloid fibrils. Am J Pathol. 1975;81:101–116.
   PubMed Web of Science ®Google Scholar
• Shirahama T, Cohen AS. An analysis of the close relationship of lysosomes to early deposits of amyloid. Ultrastructural evidence in experimental mouse amyloidosis. Am J Pathol. 1973;73:97–114.
   PubMed Web of Science ®Google Scholar
• Epstein WC, Tran M, Wood IS. Formation of “amyloid” fibrils in vitro by action of human kidney lysosomal enzymes on Bence Jones proteins. J Lab Clin Med. 1974;84:107–110.
   PubMed Web of Science ®Google Scholar
• Teng J, Turbat-Herrera EA, Herrera GA. Animal model of renal AL-amyloidogenesis depicting the crucial role of lysosomes. Kidney Int. 2014;86:738–746. doi:10.1038/ki.2014.122.
   PubMed Web of Science ®Google Scholar
• Tagouri Y, Sanders PW, Zhu I, et al. Glomerulopathic monoclonal light chains potentiate mesangial cell apoptosis in vitro (Abstract). Lab Invest. 1995;92:161A.
   Google Scholar
• Isaac J, Kerby JD, Russell WJ, et al. In-vitro modulation of AL-amyloid formation by human mesangial cells exposed to amyloidogenic light chains. Amyloid. 1998;5:238–246. doi:10.3109/13506129809007296.
   PubMed Web of Science ®Google Scholar
• Herrera GA, Shultz J, Soong S, Sanders PW. Growth factors in monoclonal light chain-related renal diseases. Hum Pathol. 1994;25:883–892. doi:10.1016/0046-8177(94)90007-8.
   PubMed Web of Science ®Google Scholar
• Herrera GA, Turbat-Herrera EA. Differential diagnosis of amyloid in surgical pathology: organized deposits and other materials in the differential diagnosis of amyloidosis. In: Picken MM, Dogan A, Herrera GA, eds. Amyloid and Related Disorders: Surgical Pathology and Clinical Correlations. Current Clinical Pathology Series. New York, NY: Humana Press, Springer; 2012:113–127.
   Google Scholar
• Alpers C. Fibrillary glomerulonephritis and immunotactoid glomerulopathy: two entities, not one. Am J Kidney Dis. 1993;22:448–451. doi:10.1016/S0272-6386(12)70151-8.
   PubMed Web of Science ®Google Scholar
• Fogo A, Qureshi N, Horn RG. Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Am J Kidney Dis. 1993;22:367–377. doi:10.1016/S0272-6386(12)70138-5.
   PubMed Web of Science ®Google Scholar
• Rosenstock JL, Markowitz GS, Valeri AM, et al. Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features. Kidney Int. 2003;63:1450–1461. doi:10.1046/j.1523-1755.2003.00853.x.
   PubMed Web of Science ®Google Scholar
• Alpers C, Kowaleska J. Fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol. 2008;19:34–37. doi:10.1681/ASN.2007070757.
   PubMed Web of Science ®Google Scholar
• Iskandar SS, Falk RJ, Jennette C. Clinical and pathologic features of fibrillary glomerulonephritis. Kidney Int. 1992;42:1401–1407. doi:10.1038/ki.1992.433.
   PubMed Web of Science ®Google Scholar
• Alexander MP, Desari S, Vrana JA, et al. Congophilic fibrillary glomerulonephritis: a case series. Am J Kidney Dis. 2018;72:325–336. doi:10.1053/j.ajkd.2018.03.017.
   PubMed Web of Science ®Google Scholar
• Nasr S, Vrana JA, Dasari S, et al. DNAJB9 is a specific immunohistochemical marker for fibrillary glomerulonephritis. Kidney Int Rep. 2018;3(1):56–64. doi:10.1016/j.ekir.2017.07.017.
   PubMed Web of Science ®Google Scholar
• Vilayur E, Trevillian P, Walsh M. Monoclonal gammopathy and glomerulopathy associated with chronic lymphocytic leukemia. Nat Clin Pract Nephrol. 2009;5:5458. doi:10.1038/ncpneph0989.
   Google Scholar
• Nasr SH, Fidler M, Cornell LD, et al. Immunotactoid glomerulopathy: clinicopathologic and proteomic study. Nephrol Dial Transplant. 2012;27:41374146. doi:10.1093/ndt/gfs348.
   Web of Science ®Google Scholar
• Ojemakinde K, Turbat-Herrera EA, Zeng X, et al. The many faces of cryoglobulinemic nephropathy: a clinico-pathologic study of 47 cases with emphasis on the value of electron microscopy. Ultrastruct Pathol. 2014;38:367376. doi:10.3109/01913123.2014.952803.
   Web of Science ®Google Scholar
• Herrera GA, Ojemakinde KO, Turbat-Herrera EA, et al. Immunotactoid glomerulopathy and cryoglobulinemic nephropathy: two entities with many similarities. A unified conceptual approach. Ultrastruct Pathol. 2015;39(4):270–280. doi:10.3109/01913123.2015.1017070.
   PubMed Web of Science ®Google Scholar